Search clinical trials for: DSM265 400mg

Total 1703 results

Kirby Institute

Recruiting

Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir (STRIVE-4)

Hepatitis C

Australia
Samyang Biopharmaceuticals Corporation
Severance Hospital

Completed

Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

Healthy

Korea, Republic of
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Not yet recruiting

A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

Sinusitis

China
Supernus Pharmaceuticals, Inc.

Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD

ADHD

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Recruiting

Cannabidiol in Opioid Use Disorder and Chronic Pain

Chronic Pain

United States
The Christ Hospital
Gilead Sciences

Completed

Transmission of Chronic Hepatitis C in Pregnancy

Hepatitis C | Pregnancy Complications | Vertical Disease Transmission

United States
KGK Science Inc.
ChromaDex, Inc.

Completed

A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects (14NBHC)

Pharmacokinetics

Canada
University of California, Los Angeles

Completed

Therapeutic Response of Cannabidiol in Rheumatoid Arthritis

Rheumatoid Arthritis | Cannabis

United States
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (OZ/DSMCombo)

Malaria

Australia
Fox Chase Cancer Center

Withdrawn

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA) (CARMA)

Metastatic Urothelial Carcinoma
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis

Dermatitis, Atopic

China
Galmed Research and Development, Ltd.

Enrolling by invitation

Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment

Hepatic Impairment

United States
GlaxoSmithKline

Completed

A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.

Hepatitis C

United States
CTI BioPharma
Covance

Completed

To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects

Drug Interaction Study

United States
CStone Pharmaceuticals
Blueprint Medicines Corporation

Completed

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
University of Baghdad

Recruiting

Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars

Post Operative Pain

Iraq
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Shanghai Mental Health Center

Completed

Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

Cognitive Impairment | Alzheimer Disease

China
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; Queensland Institute...

Terminated

A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (DSMOZ-2)

Malaria

Australia
University of Nottingham
University of Oxford; Nottingham University Hospitals NHS Trust; University of... and other collaborators

Completed

Helicobacter Eradication Aspirin Trial (HEAT)

Bacterial Infection Due to Helicobacter Pylori (H. Pylori) | Gastrointestinal Ulcer Haemorrhage

United Kingdom
Shaheer A. Khan
AstraZeneca; Melanoma Research Alliance

Completed

Intermittent Selumetinib for Uveal Melanoma

Uveal Melanoma

United States
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

Dyslipidemias | Dyslipidaemias

United States
Corcept Therapeutics

Completed

First-in-human Study in Healthy Subjects

Healthy

United Kingdom
Yasmin Hurd

Recruiting

Cannabidiol for Opioid Addiction

Opioid Use Disorder

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

CML, Chronic Phase

China
Taibah University

Completed

The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients

Chronic Periodontitis, Generalized
Global Alliance for TB Drug Development

Completed

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis Infection

United States
London School of Hygiene and Tropical Medicine
Emory University

Terminated

Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi (FED)

Lymphatic Filariasis

Malawi
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
The First Hospital of Jilin University

Recruiting

Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma (MB07133)

Efficacy | Safety Issues | MTD

China
University of Illinois at Chicago

Recruiting

A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) (LUNG-IST-127)

Metastatic Squamous Non-Small Cell Lung Carcinoma

United States
Applied Biologics, LLC

Unknown

Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee (OA)

Osteoarthritis, Knee

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Novartis Pharmaceuticals; The Skip Viragh Foundation

Terminated

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

United States
Yasmin Hurd

Completed

Cannabidiol in the Treatment of Opioid Use Disorder

Opioid Use Disorder

United States
LG Chem

Completed

Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

Hyperuricemia | Gout | Qt Interval, Variation in

United States
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Ciclosporin

Healthy

United Kingdom
Kirby Institute

Completed

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. (ENCORE1)

HIV Infections

Australia
Genzyme, a Sanofi Company

Completed

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Colorectal Cancer

Germany
Medicines for Malaria Venture
University of Cape Town

Terminated

Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteers

Malaria

South Africa
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

Chronic Hepatitis B

China
University of Kansas Medical Center
Ohio State University; Nationwide Children's Hospital; University of Cincinnati

Completed

Assessment of DHA On Reducing Early Preterm Birth (ADORE)

Preterm Birth

United States
GlaxoSmithKline

Terminated

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Epilepsy

Thailand, Korea, Republic of, Singapore, Hong Kong, Taiwan, Malaysia, Philippines
Hyundai Pharmaceutical Co., LTD.

Completed

To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers

Healthy Male
University of Florida
AbbVie; University of North Carolina, Chapel Hill

Completed

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Hepatitis C | HCV

United States
The Cleveland Clinic
Novartis

Completed

Canakinumab in Covid-19 Cardiac Injury (The Three C Study)

COVID-19 | SARS-CoV 2

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

Chronic Hepatitis C

Japan
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML

CML, CML-CP,MMR,TKI

China
Suzhou Zanrong Pharma Limited

Recruiting

Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors

Advanced Solid Tumors | HER2-positive Breast Cancer

China
Northumbria University
Nektium Pharma SL

Completed

Acute Dose-ranging Effects of Mango Leaf Extract (Zynamite® 15%) on Cognitive Function and Cerebral Blood Flow

Cognitive Change

United Kingdom
CTI BioPharma
SGS S.A.

Completed

Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects

Myelofibrosis

Moldova, Republic of, Germany
University College, London

Recruiting

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Cancer | Breast Cancer | Colorectal Cancer | Prostate Cancer | Gastro-oesophageal Cancer

Ireland, United Kingdom
Peng Wang, MD PhD

Completed

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

Solid Tumor

United States

Search clinical trials for: DSM265 400mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations